140 related articles for article (PubMed ID: 17308895)
21. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
22. HIV incidence and prevalence among aboriginal peoples in Canada.
Duncan KC; Reading C; Borwein AM; Murray MC; Palmer A; Michelow W; Samji H; Lima VD; Montaner JS; Hogg RS
AIDS Behav; 2011 Jan; 15(1):214-27. PubMed ID: 20799061
[TBL] [Abstract][Full Text] [Related]
23. Distribution and determinants of critical illness among status Aboriginal Canadians. A population-based assessment.
Laupland KB; Karmali S; Kirkpatrick AW; Crowshoe L; Hameed SM
J Crit Care; 2006 Sep; 21(3):243-7. PubMed ID: 16990090
[TBL] [Abstract][Full Text] [Related]
24. Incidence of hepatitis C virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: increasing rates of HCV diagnosis but not of HCV seroconversions.
Sobrino-Vegas P; Monge Corella S; Serrano-Villar S; Gutiérrez F; Blanco JR; Santos I; del Romero J; Segura F; Portilla J; Guillén SM; del Amo J;
PLoS One; 2014; 9(12):e116226. PubMed ID: 25549224
[TBL] [Abstract][Full Text] [Related]
25. Rate of methadone use among Aboriginal opioid injection drug users.
Wood E; Montaner JS; Li K; Barney L; Tyndall MW; Kerr T
CMAJ; 2007 Jul; 177(1):37-40. PubMed ID: 17606937
[TBL] [Abstract][Full Text] [Related]
26. First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario.
Gordon J; Bocking N; Pouteau K; Farrell T; Ryan G; Kelly L
Can Fam Physician; 2017 Nov; 63(11):e488-e494. PubMed ID: 29138174
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection among First Nation and non-First Nation people in Manitoba, Canada: a public health laboratory study.
Dawood M; Smart G; Wood M; Wu HX; Paton S; Wu J
Can J Microbiol; 2006 Oct; 52(10):999-1005. PubMed ID: 17110969
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of hepatitis C viral infection in Faisalabad, Pakistan: a retrospective study (2010-2012).
Maan MA; Hussain F; Jamil M
Afr Health Sci; 2014 Dec; 14(4):810-5. PubMed ID: 25834487
[TBL] [Abstract][Full Text] [Related]
29. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
[TBL] [Abstract][Full Text] [Related]
30. The epidemiology of hepatitis C in a Canadian Indigenous population.
Uhanova J; Tate RB; Tataryn DJ; Minuk GY
Can J Gastroenterol; 2013 Jun; 27(6):336-40. PubMed ID: 23781516
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus acquisition among Egyptians: analysis of a 10-year surveillance of acute hepatitis C.
Mohsen A; Bernier A; LeFouler L; Delarocque-Astagneau E; El-Daly M; El-Kafrawy S; El-Mango S; Abdel-Hamid M; Gadallah M; Esmat G; Mohamed MK; Fontanet A
Trop Med Int Health; 2015 Jan; 20(1):89-97. PubMed ID: 25336067
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system.
Spada E; Mele A; Mariano A; Zuccaro O; Tosti ME;
J Med Virol; 2013 Mar; 85(3):433-40. PubMed ID: 23280786
[TBL] [Abstract][Full Text] [Related]
33. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
Boodram B; Golub ET; Ouellet LJ
Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
[TBL] [Abstract][Full Text] [Related]
34. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
35. Surveillance for acute viral hepatitis - United States, 2007.
Daniels D; Grytdal S; Wasley A;
MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
[TBL] [Abstract][Full Text] [Related]
37. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
Suryaprasad AG; White JZ; Xu F; Eichler BA; Hamilton J; Patel A; Hamdounia SB; Church DR; Barton K; Fisher C; Macomber K; Stanley M; Guilfoyle SM; Sweet K; Liu S; Iqbal K; Tohme R; Sharapov U; Kupronis BA; Ward JW; Holmberg SD
Clin Infect Dis; 2014 Nov; 59(10):1411-9. PubMed ID: 25114031
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus seroconversion among young injection drug users: relationships and risks.
Hahn JA; Page-Shafer K; Lum PJ; Bourgois P; Stein E; Evans JL; Busch MP; Tobler LH; Phelps B; Moss AR
J Infect Dis; 2002 Dec; 186(11):1558-64. PubMed ID: 12447730
[TBL] [Abstract][Full Text] [Related]
39. The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals.
Leslie WD; Derksen S; Prior HJ; Lix LM; Metge C; O'neil J
Osteoporos Int; 2006; 17(9):1358-68. PubMed ID: 16770522
[TBL] [Abstract][Full Text] [Related]
40. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
